menu
    • menu

    Company profile for LB Pharmaceuticals

    NEW Drugs in Dev: 2
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    LB Pharmaceuticals is a development stage life sciences company devoted to commercializing novel and improved versions of successful CNS treatments used extensively overseas but never developed, approved, or marketed, in the United States. We believe that there are a number of ‘gold standard’ CNS therapies with excellent safety and efficacy profiles that, for various financial reasons, have never become FDA approved. Our a...
    LB Pharmaceuticals is a development stage life sciences company devoted to commercializing novel and improved versions of successful CNS treatments used extensively overseas but never developed, approved, or marketed, in the United States. We believe that there are a number of ‘gold standard’ CNS therapies with excellent safety and efficacy profiles that, for various financial reasons, have never become FDA approved. Our approach is to create a research-focused organization dedicated to generating novel intellectual property around improved versions of these former best-selling drugs.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    LB PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    575 Madison Avenue New York, NY 10022
    Telephone
    Telephone
    646-588-8175
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://lbpharma.us/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Bio-Europe Spring

    Bio-Europe Spring

    Not Confirmed

    envelop Contact Supplier

    Bio-Europe Spring

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    LB Pharma Presents NOVA-1 LB-102 Cognition Data at SIRS Society
    LB Pharma Presents NOVA-1 LB-102 Cognition Data at SIRS Society

    27 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/27/3263952/0/en/LB-Pharmaceuticals-Presents-New-Analysis-from-the-Phase-2-NOVA-1-Trial-Highlighting-LB-102-s-Potential-Impact-on-Cognitive-Performance-at-the-2026-Annual-Congress-of-the-Schizophre.html

    GLOBENEWSWIRE
    27 Mar 2026
    Share Share
    LB Pharma Reveals 2025 Financials, Corporate Update
    LB Pharma Reveals 2025 Financials, Corporate Update

    26 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/26/3263403/0/en/LB-Pharmaceuticals-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    26 Mar 2026
    Share Share
    LB Pharma Starts Pivotal Ph 3 Trial of LB-102 in Schizophrenia
    LB Pharma Starts Pivotal Ph 3 Trial of LB-102 in Schizophrenia

    25 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/25/3262125/0/en/LB-Pharmaceuticals-Initiates-Pivotal-Phase-3-Trial-NOVA-2-for-LB-102-in-Patients-with-Schizophrenia.html

    GLOBENEWSWIRE
    25 Mar 2026
    Share Share
    LB Pharma Appoints R&D Biotech Exec Dr. Robert Lenz To Board
    LB Pharma Appoints R&D Biotech Exec Dr. Robert Lenz To Board

    09 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/09/3251773/0/en/LB-Pharmaceuticals-Appoints-R-D-Biotech-Executive-Robert-Lenz-M-D-Ph-D-to-Board-of-Directors.html

    GLOBENEWSWIRE
    09 Mar 2026
    Share Share
    LB Pharma Joins March Investor Conference
    LB Pharma Joins March Investor Conference

    04 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/04/3249722/0/en/LB-Pharmaceuticals-to-Participate-in-Upcoming-March-Investor-Events.html

    GLOBENEWSWIRE
    04 Mar 2026
    Share Share
    Psychedelic Biotechs Advance CNS Treatments To Phase 3
    Psychedelic Biotechs Advance CNS Treatments To Phase 3

    27 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/psychedelic-biotechs-push-toward-phase-3-five-companies-advancing-cns-treatments-302699781.html

    PR NEWSWIRE
    27 Feb 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search